Drug Shortage Report for TARO-MEROPENEM

Last updated on 2026-03-02

Report ID 237299
Drug Identification Number 02421526
Brand name TARO-MEROPENEM
Common or Proper name Merepenem
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) MEROPENEM
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 1Vial
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2026-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v24 2026-03-02 French Compare
v23 2026-03-02 English Compare
v22 2026-02-23 French Compare
v21 2026-02-23 English Compare
v20 2026-02-06 French Compare
v19 2026-02-06 English Compare
v18 2025-12-05 French Compare
v17 2025-12-05 English Compare
v16 2025-11-11 French Compare
v15 2025-11-11 English Compare
v14 2025-10-06 French Compare
v13 2025-10-06 English Compare
v12 2025-07-07 French Compare
v11 2025-07-07 English Compare
v10 2025-06-04 French Compare
v9 2025-06-04 English Compare
v8 2025-05-20 French Compare
v7 2025-05-20 English Compare
v6 2025-01-28 French Compare
v5 2025-01-28 English Compare

Showing 1 to 20 of 24